Single and Combined Effects of Behavioral, Academic, and Medication Treatments for ADHD in the Classroom

Phase

Condition

Attention Deficit/hyperactivity Disorder (Adhd - Adults)

Williams Syndrome

Treatment

General Classroom

Academic Accommodations

Methylphenidate Hydrochloride ER

Clinical Study ID

NCT05469386

800013424

Ages 5-12
All Genders

Study Summary

This study is the first to systematically evaluate the efficacy of single and combined academic accommodation, behavioral treatment, and medication treatment in a large sample of children with ADHD. Using a scientifically rigorous, cross-over design the impact of these approaches on ecologically valid measures of outcome (on-task behavior, quiz scores, academic productivity) will be assessed to inform effective school intervention.

Eligibility Criteria

Inclusion

Inclusion Criteria:

ADHD Diagnosis
IQ >= 70

Exclusion

Exclusion Criteria:

Prior adverse reaction to methylphenidate
Autism Spectrum disorder level 2/3
Child is home schooled

Study Design

General Classroom

June 13, 2022

August 31, 2026

Connect with a study center

FIU Center for Childern and Families
Miami, Florida 33199
United States
Site Not Available
FIU Center for Childern and Families
Miami 4164138, Florida 4155751 33199
United States
Site Not Available
Center for Children and Families
Amherst, New York 14226
United States
Site Not Available
Center for Children and Families
Amherst 5107129, New York 5128638 14226
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.